Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 1

Written report Shows Rabeprazole Provides First-Dose Heartburn Decrease
.

New
York (MedscapeWire) Jun 1 — In a memoriser presented at the reference
work Digestive Disease Week (DDW) geographic point, patients with non-
erosive ebb disease (NERD) experienced significant indicant advance for
both daytime and night-time heartburn after taking rabeprazole
(Pariet/Aciphex).
Patients treated with the drug showed evidence match on the first base
day with the starting time dose.

The
double-blind, multicenter, placebo-controlled written report, presented
by the Oklahoma Grounding for Digestive Problem solving on place of the
participating sites, involved 203 patients with endoscopically
confirmed NERD.
The cogitation assessed gastroesophageal ebb disease (GERD) symptoms,
including daytime and night-time heartburn, over a point of 4 weeks.
Patients taking rabeprazole (10 mg or 20 mg once daily) experienced
significant indication status for both daytime and night-time
heart-burn vs patients receiving vesper (P<.01).
This change of state was seen on the get-go day with the low dose of
rabeprazole.

This is a part of article Study Shows Rabeprazole Provides First-Dose Heartburn Relief. Part 1 Taken from "Generic Aciphex (Rabeprazole) Review" Information Blog